Q-omics provides the consensus-scored MIR4767 profile across patient tissues and cancer cell-line models. MIR4767 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, MIR4767 is differentially expressed in 3, with the highest sampling consensus in THCA. Additionally, MIR4767 RNA expression shows 13,342 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KIRC, THCA, and UVM as cancer lineages where MIR4767 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4767 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4767 survival associations across molecular data types. MIR4767 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4767 RNA expression–survival associations across cancer types. High MIR4767 expression shows unfavorable associations in DLBC, UCS, LUSC, LUAD and BLCA, but favorable associations in KIRC. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for MIR4767 RNA expression.
This table summarizes MIR4767 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4767. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4767 shows lower tumor expression in THCA and higher tumor expression in LIHC and READ. The THCA box plot shows higher MIR4767 RNA expression in normal versus tumor tissue (log2 FC = −0.352, t-test p = .018).
This table shows molecular features associated with MIR4767 in patient tissues and cancer cell lines. In patient samples, MIR4767 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
